Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Forms Subsidiary in India

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen today said that it has established a subsidiary in New Delhi, India, to sell its products directly to the Indian market.

The firm had been using distributors for its products in the country, but it believes setting up the new subsidiary will further its growth in the emerging market.

Qiagen expects the New Delhi office will have more than 30 employees by the end of this year.

India's life sciences and biotech market provided industry-wide revenues of $5 billion in 2010, and it is expected to double by 2015, according to Qiagen. In addition, the firm said that India's in vitro diagnostics industry is projected to grow 15 percent annually over the next several years and "accelerate going forward due to government incentive programs and infrastructure investment."

"The great potential for our molecular diagnostic technologies to serve patients in India, along with the research needs of the country's robust pharmaceutical segment, emerging applied testing market, and a rapidly increasing academic market, makes India a perfect fit for our growth and geographic expansion goals," Qiagen CEO Peer Schatz said in a statement.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.